Semaglutide
STEP 3
Novo Nordisk · Phase 3 · Completed · Enrollment 611
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide | n/r | n/r | n/r | n/r | n/r |
| Semaglutide placebo | n/r | n/r | n/r | n/r | n/r |
| Semaglutide 2.4 mg, in trial | 237 participants | 111 participants | 147 participants | n/r | 0 |
| Placebo, in trial | 45 participants | 22 participants | 45 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.